Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2016-05-10 Interim / Quarterly Rep…
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
BALCHEM CORPORATION 10-Q 3-31-2016
Interim / Quarterly Report Q1 2016
2016-05-10 English
BALCHEM CORPORATION 8-K 5-10-2016
Earnings Release Classification · 95% confidence The document is a Form 8-K filed by Balchem Corporation dated May 10, 2016. It reports earnings for the first quarter ended March 31, 2016, and includes a press release as Exhibit 99.1. The text explicitly states this is a current report and the press release is attached. The document length is 2766 characters, which is relatively short and consistent with an earnings release announcement rather than a full quarterly report. The document does not contain detailed financial statements or substantive financial data itself, but rather announces the earnings results and includes a press release. According to the rules, initial announcements of quarterly financial results with key highlights only are classified as Earnings Release (ER). Therefore, this document is best classified as an Earnings Release (ER).
2016-05-10 English
FORM 4
Director's Dealing
2016-05-02 English
BALCHEM CORPORATION DEF 14A 6-15-2016
Proxy Solicitation & Information Statement
2016-04-28 English
FORM 4
Director's Dealing
2016-04-21 English
FORM 4
Director's Dealing
2016-03-23 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.